Although the underlying mechanisms of this association are unclear, alpha-synuclein has been shown to modulate lipid metabolism in PD models (Golovko et al., 2007; Sharon et al., 2003; Zambon et al., 2019). Here, SNCA is linked to Parkinson disease.